ArticleNature2019
Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences.
Abstract readPublished Erratum
In one paragraph
Article in Nature, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Multi-Omics Mining of lncRNAs with Biological and Clinical Relevance in Cancer.International journal of molecular sciences · 2023Review
- Influence network model uncovers relations between biological processes and mutational signatures.Genome medicine · 2023Article
- Examining clustered somatic mutations with SigProfilerClusters.Bioinformatics (Oxford, England) · 2022Article
- Targeting the replication stress response through synthetic lethal strategies in cancer medicine.Trends in cancer · 2021Review
- Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.Frontiers in immunology · 2021Article
- Impact of TP53 mutations in breast cancer: Clinicopathological features and prognosisImpact of TP53 mutations in breast CA.Thoracic cancer · 2020Article
- Using whole-genome sequencing data to derive the homologous recombination deficiency scores.NPJ breast cancer · 2020Article
- SigProfilerMatrixGenerator: a tool for visualizing and exploring patterns of small mutational events.BMC genomics · 2019Article
Corrections and comments
- Erratum for
Authors and funding
88 authors.
Serena Nik-ZainalWellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK. snz@sanger.ac.uk.
Helen DaviesWellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
Johan StaafDivision of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, SE-223 81, Sweden.
Manasa RamakrishnaWellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
Dominik GlodzikWellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
Xueqing ZouWellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
Inigo MartincorenaWellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
Ludmil B AlexandrovWellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
Sancha MartinWellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
David C WedgeWellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
Peter Van LooWellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
Young Seok JuWellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
Marcel SmidDepartment of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam, 3015CN, The Netherlands.
Arie B BrinkmanRadboud University, Department of Molecular Biology, Faculty of Science, 6525GA, Nijmegen, The Netherlands.
Sandro MorganellaEuropean Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SD, UK.
Miriam R AureDepartment of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, 0310, Norway.
Ole Christian LingjærdeK. G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, 0310, Norway.
Anita LangerødDepartment of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, 0310, Norway.
Markus RingnérDivision of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, SE-223 81, Sweden.
Sung-Min AhnGachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Incheon, South Korea.
Sandrine BoyaultTranslational Research Lab, Centre Léon Bérard, 28, rue Laënnec, 69373, Lyon Cedex 08, France.
Jane E BrockDepartment of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, 02115, USA.
Annegien BroeksThe Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands.
Adam ButlerWellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
Christine DesmedtBreast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Bd de Waterloo 121, B-1000, Brussels, Belgium.
Luc DirixTranslational Cancer Research Unit, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
Serge DronovWellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
Aquila FatimaDana-Farber Cancer Institute, Boston, Massachusetts, 02215, USA.
John A FoekensDepartment of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam, 3015CN, The Netherlands.
Moritz GerstungWellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
Gerrit K J HooijerDepartment of Pathology, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Se Jin JangDepartment of Pathology, Asan Medical Center, College of Medicine, Ulsan University, Ulsan, South Korea.
David R JonesWellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
Hyung-Yong KimDepartment of Pathology, College of Medicine, Hanyang University, Seoul, 133-791, South Korea.
Tari A KingMemorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York, 10065, USA.
Savitri KrishnamurthyMorgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard., Houston, Texas, 77030, USA.
Hee Jin LeeDepartment of Pathology, Asan Medical Center, College of Medicine, Ulsan University, Ulsan, South Korea.
Jeong-Yeon LeeInstitute for Bioengineering and Biopharmaceutical Research (IBBR), Hanyang University, Seoul, South Korea.
Yilong LiWellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
Stuart McLarenWellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
Andrew MenziesWellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
Ville MustonenWellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
Sarah O'MearaWellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
Iris PauportéInstitut National du Cancer, Research Division, Clinical Research Department, 52 avenue Morizet, 92513, Boulogne-Billancourt, France.
Xavier PivotUniversity Hospital of Minjoz, INSERM UMR 1098, Bd Fleming, Besançon, 25000, France.
Colin A PurdiePathology Department, Ninewells Hospital and Medical School, Dundee, DD1 9SY, UK.
Keiran RaineWellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
Kamna RamakrishnanWellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
F Germán Rodríguez-GonzálezDepartment of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam, 3015CN, The Netherlands.
Gilles RomieuOncologie Sénologie, ICM Institut Régional du Cancer, Montpellier, France.
Anieta M SieuwertsDepartment of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam, 3015CN, The Netherlands.
Peter T SimpsonThe University of Queensland, UQ Centre for Clinical Research and School of Medicine, Brisbane, Queensland, 4029, Australia.
Rebecca ShepherdWellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
Lucy StebbingsWellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
Olafur A StefanssonCancer Research Laboratory, Faculty of Medicine, University of Iceland, 101, Reykjavik, Iceland.
Jon TeagueWellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
Stefania TommasiIRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Isabelle TreilleuxDepartment of Pathology, Centre Léon Bérard, 28 rue Laënnec, 69373, Lyon Cédex 08, France.
Gert G Van den EyndenTranslational Cancer Research Unit, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
Peter VermeulenTranslational Cancer Research Unit, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
Anne Vincent-SalomonInstitut Curie, Paris Sciences Lettres University, Department of Pathology and INSERM U934, 26 rue d'Ulm, 75248, Paris Cedex 05, France.
Lucy YatesWellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
Carlos CaldasCancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK.
Laura Van't VeerThe Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands.
Andrew TuttBreast Cancer Now Research Unit, King's College London, London, SE1 9RT, UK.
Stian KnappskogDepartment of Clinical Science, University of Bergen, 5020, Bergen, Norway.
Benita Kiat Tee TanNational Cancer Centre Singapore, 11 Hospital Drive, 169610, Singapore, Singapore.
Jos JonkersThe Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands.
Åke BorgDivision of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, SE-223 81, Sweden.
Naoto T UenoMorgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard., Houston, Texas, 77030, USA.
Christos SotiriouBreast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Bd de Waterloo 121, B-1000, Brussels, Belgium.
Alain ViariEquipe Erable, INRIA Grenoble-Rhône-Alpes, 655, Avenue de l'Europe, 38330, Montbonnot-Saint Martin, France. Alain.Viari@inria.fr.
P Andrew FutrealWellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
Peter J CampbellWellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
Paul N SpanDepartment of Radiation Oncology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, 6525GA, The Netherlands.
Steven Van LaereTranslational Cancer Research Unit, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
Sunil R LakhaniThe University of Queensland, UQ Centre for Clinical Research and School of Medicine, Brisbane, Queensland, 4029, Australia.
Jorunn E EyfjordCancer Research Laboratory, Faculty of Medicine, University of Iceland, 101, Reykjavik, Iceland.
Alastair M ThompsonPathology Department, Ninewells Hospital and Medical School, Dundee, DD1 9SY, UK.
Ewan BirneyEuropean Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SD, UK.
Hendrik G StunnenbergRadboud University, Department of Molecular Biology, Faculty of Science, 6525GA, Nijmegen, The Netherlands.
Marc J van de VijverDepartment of Pathology, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
John W M MartensDepartment of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam, 3015CN, The Netherlands.
Anne-Lise Børresen-DaleDepartment of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, 0310, Norway.
Andrea L RichardsonDepartment of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, 02115, USA.
Gu KongDepartment of Pathology, College of Medicine, Hanyang University, Seoul, 133-791, South Korea. gkong@hanyang.ac.kr.
Gilles ThomasSynergie Lyon Cancer, Centre Léon Bérard, 28 rue Laënnec, Lyon Cedex 08, France.
Michael R StrattonWellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK. mrs@sanger.ac.uk.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the Methods section of this Article, 'greater than' should have been 'less than' in the sentence 'Putative regions of clustered rearrangements were identified as having an average inter-rearrangement distance that was at least 10 times greater than the whole-genome average for the individual sample. '. The Article has not been corrected.
Identifiers
PMID
30659290What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.